Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
NeovascularizationTuberculosisMultifocal Serpiginous ChoroiditisHarada Toxoplasmosis
Trial Locations (1)

1136044

American University of Beirut, Beirut

All Listed Sponsors
collaborator

Heidelberg University

OTHER

collaborator

University Hospital Tuebingen

OTHER

collaborator

University Hospital Freiburg

OTHER

lead

Rafic Hariri University Hospital

OTHER

NCT00645697 - Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization | Biotech Hunter | Biotech Hunter